Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

antineoplaston AS 2-1 × Endocrine × 1 year × Clear all

Sponsor

Cancer Type

Interventions

lutetium Lu 177 dotatate 27 Magnetic Resonance Spectroscopy 21 pembrolizumab 17 Specimen Handling 16 Nivolumab 15 Everolimus 14 gallium Ga 68 dotatate 10 Ipilimumab 10 cabozantinib 9 trametinib 8 lenvatinib 8 dabrafenib 8 Cisplatin 8 Carboplatin 8 Temozolomide 7 Capecitabine 7 atezolizumab 6 X-Rays 5 Vemurafenib 5 Octreotide 5 Injections 5 Fluorodeoxyglucose F18 5 Etoposide 5 Disulfides 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 surufatinib 4 selpercatinib 4 amino-acid, glucose, and electrolyte solution 4 Surveys and Questionnaires 4 Paclitaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡